Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2008
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008122020A1 Substituted pyrimidines
10/09/2008WO2008121861A2 Pyrazole and pyrrole compounds useful in treating iron disorders
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008121670A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120754A1 Picolinamide compound
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008119825A2 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119804A1 New methods
10/09/2008WO2008119741A2 3-imidazolyl-indoles for the treatment of proliferative diseases
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008002245A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2008002244A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008WO2007107706A3 Dimers of heterocyclic compounds for the treatment of copd
10/09/2008US20080249301 Regioselective Process for Preparing Benzimidazole Thiophenes
10/09/2008US20080249290 Colorant compounds
10/09/2008US20080249149 Serotonin receptor antagonists
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249134 New Esomeprazole Sodium Salt Crystal Modification
10/09/2008US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249106 3-(1-((R)-7-((4-fluoropiperidin-1-yl)methyl)-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)-2-(4-methylphenylsulfonamido)propanoic acid; chronic pain analgesics; side effect reduction
10/09/2008US20080249101 BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES
10/09/2008US20080249099 7-Phenylalkyl Substituted 2-Quinolinones and 2-Quinoxalinones as Poly(Adp-Ribose) Polymerase Inhibitors
10/09/2008US20080249095 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas
10/09/2008US20080249090 1-(4-(1H-pyrrol-1-yl)phenyl)-3-(2-aminoquinazolin-6-yl)-4-methylpyridin-2(1H)-one; modulators of kinase enzymes such as c-kit, and useful for the regulation of autoimmune disease(s), allergies, asthma, cancer and the like
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008US20080249081 Compounds for the treatment of pain and screening methods therefor
10/09/2008US20080249079 Pyrimidine Derivatives As Kinase Modulators and Method of Use
10/09/2008US20080247992 N-Carboxyalkyl-1-cyclohexyl-2-substituted phenylbenzimidazole-5-carboxamides (2-[(1-cyclohexyl-2-{2-fluoro-4-[3-(aminocarbonyl)-6-(4-chlorophenyl)benzyloxy]-phenyl}-1H-benzimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid); Flavivirus family infections such as hepatitus C
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682708A1 Substituted pyrimidines
10/09/2008CA2682649A1 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008CA2682629A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008CA2682483A1 3-imidazolyl-indoles for the treatment of proliferative diseases
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2681203A1 New methods
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008EP1978023A1 Pyridazines as fungicides
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976848A2 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1725546B1 Pyrazolyl indolyl derivatives as ppar activators
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1497351B1 Low-viscosity polyisocyanate composition having high functionality and method for preparing same
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1341785B1 Hydrolysis of r(r*,r*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282966A Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
10/08/2008CN101282965A Alkoxy indolinone based protein kinase inhibitors
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282943A Pyrimidine amide compounds as PGDS inhibitors
10/08/2008CN101282942A Imidazole derivatives for the treatment of anxiety and related diseases
10/08/2008CN101282941A Imidazole compounds for the treatment of neurological disorders
10/08/2008CN101282938A Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/08/2008CN101281266A Filter for electronic display
10/08/2008CN101281265A Filter for electronic display
10/08/2008CN101279971A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same
10/08/2008CN101279970A 2-methyl-5-azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutied derivate, preparation and application thereof
10/08/2008CN100424083C Pyrimidine derivative compound and its preparing method
10/08/2008CN100424080C Quinoxaline derivatives as neutrophil elastase inhibitors and their use
10/08/2008CN100424079C Bis-sulfonamides
10/08/2008CN100424078C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432378 For example, 2-{2-Chloro-4-[3-(4-methyl-piperazin-1-yl)-propoxy]-phenyl}-4,5-dimethyl-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008117935A1 Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
10/02/2008WO2008117826A1 Compound for organic electroluminescent device and organic electroluminescent device
10/02/2008WO2008117303A1 Indole derivatives and their metal conjugates and uses thereof
10/02/2008WO2008117079A1 Antimicrobial compounds based upon 4-aminoquinoline
10/02/2008WO2008117050A1 Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer
10/02/2008WO2008116833A1 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008099076A3 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2008094507A3 Novel fusion compounds
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008062167A3 Melatonin derivatives and their use as antioxidants
10/02/2008WO2008059259A3 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core
10/02/2008WO2007139968A3 Triazole compounds that modulate hsp90 activity
10/02/2008US20080242871 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
10/02/2008US20080242862 Novel imidazo based heterocycles
10/02/2008US20080242725 pharmaceutical ingredients susceptible to conversion to alternate polymorph forms are prepared by a process of wet granulation in which the ratios of active, fillers, and granulating liquid are controlled in order to avoid polymorphic interconversions
10/02/2008US20080242716 Ion Channel Modulators
10/02/2008US20080242701 Antitumor agents; anticancer agents; cytotoxic activity; angiogenesis inhibitor; leukemia; colorectal cancer; administering by mouth
10/02/2008US20080242687 endothelin modulators/antagonists; reduced hepatoxicity; hypotensive agents; Deuterated Pyrimidine Derivatives like 4-tert-Butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yl]-benzenesulfonamide